Science - USA (2022-04-22)

(Maropa) #1

within as-yet-unreleased granules (fig. S2C).
To determine whether some of the membra-
nous material within the intercellular space
might also have been derived from the target


cell, we examined the surface topology of the
postsynaptic target cell. We noted multiple
tubular and bud-like protrusions of the target
cell membrane that extended into the synaptic

space; thus, at least some of the membrane
structures observed were still in continuity
with the target cell (Fig. 2C and movie S6, TS
0:58 to 1:11). ESCRT proteins have been shown

SCIENCEscience.org 22 APRIL 2022¥VOL 376 ISSUE 6591 381


FSC

SSC

VPS4a
E228Q

VPS4a WT

0 ng/mL Perforin 160 ng/mL Perforin 1280 ng/mL Perforin
E

APC

Cell Count

0 ng/mL [GZMB]
+160 ng/mL [PRF]

10,000 ng/mL [GZMB]
+160 ng/mL [PRF]

*Y axis normalized to mode

VPS4a WT
VPS4a E228Q

G

(^001234)
200
400
600
800
Time (hours)


Dead cells/mm


2
N4
A
F
C
TCR:pMHC affinity






ns
Chmp4b
actin
D
TCR:pMHC affinity





  • ns
    VPS4a
    (anti-HA)
    actin
    Control Chmp4b KO
    T 0h
    T 4h
    B
    Scale 150 um
    0.6 ± 2.4
    173.0 ± 27.7
    10.1 ± 3.4
    573.4± 46.2
    Images from T4 peptide condition
    TCR:pMHC affinity

    ns ns ns **
    ns ns ns


    H
    (^001234)
    200
    400
    600
    800
    Time (hours)
    T4


    Dead cells/mm


    2
    (^001234)
    200
    400
    600
    800
    Time (hours)
    Q4H7


    Dead cells/mm


    2
    (^001234)
    200
    400
    600
    800
    Time (hours)
    G4


    Dead cells/mm


    2
    Control
    Chmp4b KO
    (^001234)
    200
    400
    600
    800
    Time (hours)
    unpulsed


    Dead cells/mm


    2
    37
    50
    37
    50
    50
    37
    ControlChmp4b KO VP
    S4
    WT
    VPS4 E228Q
    0 80 160 320 640 1280
    100
    80
    60
    40
    20
    0
    Perforin viability titration
    [mPerforin]
    ng/mL/10^6 cells
    % Live Cells
    % AnnexinV-APC+ counts
    100
    80
    60
    40
    20
    0
    5,000 GZMB0 PRF^0 2,500 5,000 10,000
    [mGZMB]
    ng/mL/10^6 cells
    VPS4a WT
    VPS4a E228Q
    VPS4a WT
    VPS4a E228Q
    Fig. 4. ESCRT inhibition enhances susceptibility of cancer cells to CTL
    killing and recombinant lytic proteins.(A) Representative time-lapse data of
    killing of peptide-pulsed Chmp4b knockout (KO) or control B16-F10 cells by OT-I
    CTLs. Affinity of the pulsed peptide to OT-I TCR decreases from left to right.
    Error bars indicate SDs. (B) Images extracted from T4 medium-affinity peptide
    condition show software-detected caspase 3/7+ events in control and Chmp4b
    KO conditions. (CandD) Data representing the 4-hour time point of assays
    measuring OT-I T cells killing either Chmp4b KO (C) or VPS4 dominant-negative
    (D) target cells with matched controls. Error bars indicate SDs of data. Data are
    representative of at least three independent experimental replicates. pMHC,
    peptide-MHC; HA, hemagglutinin. (EandF) Determination of sublytic dose of Prf.
    B16-F10 cells expressing VPS4a (WT or E228Q) were exposed to increasing
    concentrations of Prf. Cell viability was determined by morphological gating (E).
    FSC, forward scatter; SSC, side scatter. (GandH) B16-F10 cells expressing
    VPS4a (WT or E228Q) were exposed to a sublytic dose of Prf in combination with
    increasing concentrations of recombinant GZMB (rGZMB). Cell death was
    determined by Annexin VÐallophycocyanin (APC) staining (G). Controls include a
    condition with no perforin and 5000 ng/ml rGZMB and sublytic perforin with no
    rGZMB. Graphs in (F) and (H) represent the means of three experiments, and
    error bars indicate SDs. Statistical significance was determined by multiple
    unpairedttests with alpha = 0.05. ns, not significant; P< 0.05; P< 0.01;
    P< 0.001.
    RESEARCH | RESEARCH ARTICLES



Free download pdf